TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Biotechnology.

$150,000 Reported spend

6 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (67774), not by name.

Firms hired 1

B HALL STRATEGIES, LLC $150,000 6 filings

Bills named in these filings 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

1 filing

Reported by year 2 years

2026 $60,000 2 filings
2025 $90,000 4 filings

Issues lobbied 2

Pharmacy 4
Health Issues 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

SENATE 5

Recent filings 6 total

Q2

B HALL STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2026 · Senate · $30,000 income · posted Jul 19, 2026

View → Q1

B HALL STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · Senate · $30,000 income · posted Apr 9, 2026

View → Q4

B HALL STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · Senate · $30,000 income · posted Jan 19, 2026

View → Q3

B HALL STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) 2025 · Senate · $30,000 income · posted Oct 20, 2025

View → 2A

B HALL STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2025 · Senate · $30,000 income · posted Aug 5, 2025

View → RR

B HALL STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.